Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation.
Miyata
Toshio
T
Institute of Medical Sciences and Department of Medicine, Tokai, University School of Medicine, Kanagawa, Japan. t-miyata@is.icc.u-tokai.ac.jp
van Ypersele de Strihou
Charles
C
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology*; D016166:Free Radical Scavengers; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors*; D006801:Humans; D008954:Models, Biological; D028561:Transition Elements / Q000494:pharmacology*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002614:Chelating Agents; D016166:Free Radical Scavengers; D017127:Glycation End Products, Advanced; D028561:Transition Elements